2017
DOI: 10.1136/dtb.2017.1.0448
|View full text |Cite
|
Sign up to set email alerts
|

▼Pitolisant for narcolepsy

Abstract: ▼Pitolisant (Wakix-Bioprojet Pharma) is a new treatment for adults with narcolepsy with or without cataplexy. It was licensed for use in the EU in March last year and has orphan drug status. Here, we consider the evidence for pitolisant for the treatment of narcolepsy in adults and how it fits with current management strategies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 9 publications
0
0
0
Order By: Relevance